Stoke Therapeutics, Inc.

STOK

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001623526

SEC filings (opens in a new tab)

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Stoke Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of STOK: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	81	1	103	+23
Shares	45.0M	470	54.2M	+9.21M (+20.4%)
Value	$236.9M	$2.47K	$731.7M	+$494.8M (+208.9%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to STOK in Q1 2024
Institution	Shares	Value	% of portfolio
Franklin Resources Inc	1,058,300	$14.3M	0.00%
Artal Group S.A.	300,000	$4.05M	0.10%
Eversept Partners, LP	290,000	$3.92M	0.29%
Sio Capital Management, LLC	225,496	$3.04M	1.06%
Marshall Wace, LLP	178,586	$2.41M	0.00%
DAFNA Capital Management LLC	145,000	$1.96M	0.45%
Wellington Management Group LLP	143,351	$1.94M	0.00%
Point72 Asset Management, L.P.	142,458	$1.92M	0.01%
Palo Alto Investors LP	125,861	$1.70M	0.19%
Laurion Capital Management LP	100,000	$1.35M	0.04%
Maven Securities LTD	100,000	$1.35M	0.08%
Monashee Investment Management LLC	67,584	$912.4K	0.11%
Mirae Asset Global Investments Co., Ltd.	90,663	$728.0K	0.00%
Norges Bank	50,000	$675.0K	0.00%
LMR Partners LLP	50,000	$675.0K	0.02%
EAM Investors, LLC	45,845	$618.9K	0.10%
Tudor Investment Corp Et Al	33,326	$449.9K	0.01%
Ghisallo Capital Management LLC	30,000	$405.0K	0.05%
Seven Grand Managers, LLC	30,000	$405.0K	0.20%
Belvedere Trading LLC	23,665	$319.5K	0.02%
PDT Partners, LLC	21,426	$289.3K	0.03%
Chase Investment Counsel Corp	20,738	$279.0K	0.10%
Hudson Bay Capital Management LP	20,000	$270.0K	0.00%
Renaissance Technologies LLC	19,100	$258.0K	0.00%
XTX Topco Ltd	16,308	$220.2K	0.03%
Aquatic Capital Management LLC	9,600	$129.6K	0.00%
State Board of Administration of Florida Retirement System	10,473	$87.2K	0.00%
ADAR1 Capital Management, LLC	2,900	$39.1K	0.01%
Stone House Investment Management, LLC	500	$6.75K	0.00%
GAMMA Investing LLC	117	$1.58K	0.00%
Advisor Group Holdings, Inc.	61	$823	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	5	$67	0.00%

Sold out (9)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of STOK in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Ameriprise Financial Inc	22,054	$116.0K
Public Employees Retirement System of Ohio	17,283	$90.9K
Citadel Advisors LLC	15,577	$81.9K
Man Group plc	15,361	$80.8K
Algert Global LLC	12,540	$66.0K
Voya Investment Management LLC	11,175	$58.8K
Two Sigma Advisers, LP	11,000	$57.9K
Cutler Group LP	600	$3.00K
Qube Research & Technologies Ltd	35	$184

Not filed for Q1 2024 yet (1)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STOK in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Provence Wealth Management Group	470	$2.47K